Ireland
--:--IST
Recruiting Not applicable

Maximising Maternal Milk for Preterm Infant

NCT07908238 · tracked via the Priya Life Science Ireland tracker
Sponsor
National Maternity Hospital, Ireland
Phase
Not applicable
Started
2025-11-07
Last updated
2026-11-02

Condition(s) studied

BreastfeedingPrematurity

Investigational drug(s) / intervention(s)

Hospital grade double electrical breast milk pump

Hospital grade double electrical breast milk pump: Mothers assigned to the early pump group will be advised to start pumping using a hospital-grade double electrical breast pump as soon after birth(target within first 6 hours after delivery) follow by hand expression for 10 minutes for the first 48 hours then start using a hospital -grade double electrical breast pump.

Study summary

Maternal milk is the gold standard in infant nutrition, providing significant advantages, in preterm and term infants. Maternal milk plays a major role in reducing the risk of inflammatory bowel disease(NEC) in premature and low birth weight infants as well as improving neurodevelopmental outcomes in this population, In this study the investigators are comparing earlier (from birth rather than 48 hours post delivery) use of an electrical breast pump. Mothers will be selected at random to be in one of two groups: early or later pump use. The investigators will compare milk volumes achieved on day 14 post delivery between the two groups. The investigators will recruit x number of mothers of preterm infants \< 33 weeks gestation at birth

Eligibility

Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
No
Inclusion criteria: * The infant/s are born at the National Maternity Hospital with a gestational age at birth \< 33 weeks by best obstetric estimate or with a birth weight of \< 1500g; or * The infant/s are born in another centre with a gestational age at birth \< 33 weeks by best obstetric estimate and/or with a birth weight of \< 1500g and the mother is admitted to the National Maternity Hospital within 24 hours of delivery Exclusion Criteria: * Breast milk use in the infant is contraindicated * There is breast hypoplasia on examination or recent breast surgery affecting ability to produce adequate breast milk

Primary outcome measure(s)

  • Percentage of women achieving > 500mls expressed breast milk by 14 days' post-partum — from enrolment to two weeks post delivery
  • Percentage of women achieving > 500mls by 14 days' post-partum in mothers of preterm infants < 33 weeks gestation and/or 1500 gram — Milk amount from time of enrolment to two weeks post delivery
    Mothers of preterm infants \<33 weeks and /or 1500 gram will randomly assigned to early breast pumping group or late breast pumping group as outlined above , the primary outcome is the achieving of more than 500 ml of breast milk by day 14 post delivery.

Trial sites (3)

FacilityCityRegionStatus
National Maternity Hospital Dublin Co. Dublin Not Yet Recruiting
National Maternity Hospital Dublin Co. Dublin Recruiting
National Maternity Hospital Dublin Co.Dublin Suspended
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07908238 on ClinicalTrials.gov ↗ ← All trials in Ireland